The emergence of social phobia during clozapine treatment and its response to fluoxetine augmentation.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Clinical Psychiatry

• Publication date

  1999-12-31

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.4088/JCP.V60N1203PMID 10665627
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurobiology of Social Phobia

  1999cited by this paper
• Effects of clozapine on awareness of illness and cognition in schizophrenia.

  1999cited by this paper
• The Prevalence of Comorbid Anxiety in Schizophrenia, Schizoaffective Disorder and Bipolar Disorder

  1998cited by this paper
• Effect of fluoxetine on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenia.

  1998cited by this paper
• Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders.

  1998cited by this paper
• Relapse in young paranoid schizophrenic patients: a prospective study of stressful life events, P300 measures, and coping.

  1997cited by this paper
• Dopamine reuptake site densities in patients with social phobia.

  1997cited by this paper
• Fluoxetine efficacy in social phobia.

  1997cited by this paper
• Fluoxetine augmentation of clozapine treatment in patients with schizophrenia.

  1996cited by this paper
• Fluoxetine treatment of children with selective mutism: an open trial.

  1996cited by this paper
• Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking

  1996cited by this paper
• Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors.

  1996cited by this paper
• Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey.

  1996cited by this paper
• D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients.

  1995cited by this paper
• Schizotypal symptoms and signs in the Roscommon Family Study. Their factor structure and familial relationship with psychotic and affective disorders.

  1995cited by this paper
• Can clozapine trigger OCD?

  1995cited by this paper
• Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study.

  1994cited by this paper
• Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate.

  1994cited by this paper
• Magnetic resonance imaging in social phobia.

  1994cited by this paper
• Treatment of clozapine-induced obsessive-compulsive symptoms with sertraline.

  1994cited by this paper
• Lack of effect of fluoxetine on plasma clozapine concentrations.

  1994cited by this paper
• Magnetic resonance spectroscopy in social phobia: preliminary findings.

  1993cited by this paper
• "True" schizotypal personality disorder: a study of co-twins and relatives of schizophrenic probands.

  1993cited by this paper
• Development of obsessive-compulsive symptoms during clozapine treatment.

  1993cited by this paper
• Fluoxetine efficacy in social phobia.

  1993cited by this paper
• Social phobia: biological aspects and pharmacotherapy.

  1992cited by this paper
• Emergence of obsessive compulsive symptoms during treatment with clozapine.

  1992cited by this paper
• Development of transient obsessive-compulsive symptoms during treatment with clozapine.

  1992cited by this paper
• Fluoxetine for the treatment of social phobia.

  1992cited by this paper
• Anxiety disorders in patients with Parkinson's disease.

  1990cited by this paper
• School avoidance and social phobia triggered by haloperidol in patients with Tourette's disorder.

  1981cited by this paper

• Optimizing antidepressant and clozapine co-prescription in clinical practice: A systematic review and expert recommendations.

  2023cites this paper
• A Gain‐of‐Function Variant in Dopamine D2 Receptor and Progressive Chorea and Dystonia Phenotype

  2020cites this paper
• Social anxiety within a network of mild delusional ideations, negative symptoms and insight in outpatients with early psychosis: A psychopathological path analysis

  2020cites this paper
• Correlates and management of comorbid anxiety disorders in schizophrenia

  2018cites this paper
• Current and potential pharmacological and psychosocial interventions for anxiety symptoms and disorders in patients with schizophrenia: structured review

  2017cites this paper
• Social anxiety disorder co-morbid with schizophrenia: a cross-sectional study from India

  2016cites this paper
• La comorbidité entre troubles du spectre de la schizophrénie et troubles anxieux, revue de la littérature

  2016cites this paper
• Anxiety in Patients with Schizophrenia: Epidemiology and Management

  2015influential citation
• Social Anxiety Disorder Comorbid with Schizophrenia : The Importance of Screening for This Underrecognized and Undertreated Condition

  2015cites this paper
• Social Anxiety Disorder Comorbid with Schizophrenia: The Importance of Screening for This Under recognized and Under treated Condition.

  2015cites this paper
• Olfactory performance segregates effects of anhedonia and anxiety on social function in patients with schizophrenia.

  2015cites this paper
• Frequent Comorbidity and Predictors of Social Anxiety in Persons With Schizophrenia: A Retrospective Cohort Study.

  2015cites this paper
• Angst ved psykose: Forståelsesmodeller for en forhøyet forekomst av angstlidelser ved psykose

  2013cites this paper
• Anxiety comorbidity in schizophrenia.

  2013influential citation
• Pharmacological treatment of social anxiety disorder.

  2013cites this paper
• The response to sulpiride in social anxiety disorder: D2 receptor function

  2013cites this paper
• Anxiety Disorder Comorbidity in Bipolar Disorder, Schizophrenia and Schizoaffective Disorder

  2012cites this paper
• 2 Social Anxiety Disorder

  2012cites this paper
• [Clinical correlates of social anxiety disorder comorbidity in schizophrenia].

  2012cites this paper
• Lower subjective quality of life and the development of social anxiety symptoms after the discharge of elderly patients with remitted schizophrenia: a 5-year longitudinal study.

  2012cites this paper
• Clozapine decreases exploratory activity and increases anxiety-like behaviour in the Wistar-Kyoto rat but not the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder.

  2012cites this paper
• Treatment Resistant Generalized Anxiety Disorder

  2011cites this paper
• Increased dopamine transporter density in Parkinson's disease patients with Social Anxiety Disorder.

  2011cites this paper
• Social anxiety in schizophrenia: a clinical quantitative and qualitative analysis

  2011cites this paper
• Different Views of Anxiety Disorders

  2011cites this paper
• A 2010 Evidence-Based Algorithm for the Pharmacotherapy of Social Anxiety Disorder

  2010cites this paper
• Dopamine transporter binding in social anxiety disorder: the effect of treatment with escitalopram

  2010cites this paper
• Recent Advances in Understanding and Treating Social Anxiety Disorder

  2009cites this paper
• Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorder

  2009cites this paper
• Aripiprazole for the Treatment of Schizophrenia With Co-Occurring Social Anxiety: An Open-Label Cross-Taper Study

  2009cites this paper
• Comorbid anxiety in patients with psychosis.

  2009cites this paper
• Social Anxiety Disorder

  2008cites this paper
• Genetic Correlates of Adult Attachment Style

  2008cites this paper
• Striatal dopamine D2 receptor availability in OCD with and without comorbid social anxiety disorder: preliminary findings

  2008cites this paper
• The Emergence of Darkness Phobia in a Bipolar Patient During Quetiapine Treatment

  2006cites this paper
• Is obsessive-compulsive disorder an anxiety disorder?

  2006cites this paper
• The emergence of darkness phobia in a bipolar patient during quetiapine treatment.

  2006cites this paper
• Clozapine augmentation with aripiprazole for negative symptoms.

  2006cites this paper
• High-dose aripiprazole in treatment-resistant schizophrenia.

  2006cites this paper
• Simultaneous true seizures and pseudoseizures.

  2006cites this paper
• Augmentation Strategies in Clozapine-Resistant Schizophrenia

  2005cites this paper
• Social Anxiety Disorder

  2005cites this paper
• Sleep paralysis-associated sensed presence as a possible manifestation of social anxiety.

  2005cites this paper
• Overview of panic and social anxiety disorders.

  2004cites this paper
• Social anxiety in outpatients with schizophrenia: a relevant cause of disability.

  2004cites this paper
• Anxiety disorders in schizophrenia.

  2004cites this paper
• Anxiety disorders and schizophrenia

  2004cites this paper
• Aggiornamenti in PSICHIATRIA supplemento a Heroin Addiction and Related Clinical Problems

  2003cites this paper
• Fluoxetina: profilo terapeutico e farmacoeconomico di un prodotto generico

  2003cites this paper
• WCA Recommendations for the Long-Term Treatment of Social Phobia

  2003cites this paper
• Effect of low doses of clozapine on behaviour of isolated and group-housed male mice in the elevated plus-maze test.

  2002cites this paper
• Social anxiety disorder and generalized anxiety disorder: serotonergic and dopaminergic neurocircuitry.

  2002cites this paper
• Shame and Psychopathology

  2000cites this paper
• Social Anxiety and Premorbid Personality Disorders in Paranoid Schizophrenic Patients Treated With Clozapine

  2000influential citation
• Social anxiety disorder.

  1999cites this paper
• Schizophrenia and Anxiety Disorders A. Associated Sedative Anxiolytic Treatment in Acute Psychotic Manifestations of Schizophrenia

  year unknowncites this paper